Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases

Update Il y a 4 ans
Reference: NCT00875147

Woman and Man

Extract

Hypothesis of the study: Neoadjuvant chemotherapy with Bevacizumab impairs postoperative outcome after resection of colorectal liver metastases.


Inclusion criteria

  • Colorectal liver metastases

Links